| Name: | 6 6 7 7 Tetrakis 2 methoxyethoxy 4H 3 4 biquinazolin 4 one |
| Catalogue No. | VE008800 |
| CAS No. | N/A |
| Molecular Formula | C28H34N4O9 |
| Molecular Weight | 570.59 g/mol |
| Status | In-Stock |
| IUPAC Name | 6,6',7,7'-Tetrakis(2-methoxyethoxy)-4H-[3,4'-biquinazolin]-4-one |
| Description | 6,6',7,7'-Tetrakis(2-methoxyethoxy)-4H-[3,4'-biquinazolin]-4-one is an impurity of Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication. Erlotinib is in a class of medications called kinase inhibitors. |
| References | “Erlotinib: MedlinePlus Drug Information.” Medlineplus.gov, 2017, medlineplus.gov/druginfo/meds/a605008.html. |
